Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C9SY
|
||||
Former ID |
DAP000414
|
||||
Drug Name |
Vardenafil
|
||||
Synonyms |
VDN; Levitra (TN); VARDENAFIL, LEVITRA; Vardenafil (INN); 1-((3-(3,4-Dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine; 2-(2-Ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3H-imidazo(5,1-f)(1,2,4)triazin-4-one; 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one; 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE; 2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antiimpotence Agents
|
||||
Company |
Bayer Pharmaceuticals Corporation
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H32N6O4S
|
||||
InChI |
InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)
|
||||
InChIKey |
SECKRCOLJRRGGV-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 224785-90-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
585747, 833312, 7891048, 7980307, 10235224, 14785997, 14932815, 28477354, 44439098, 46506777, 46515101, 48034817, 49737956, 50012454, 50112786, 50365874, 53787736, 60818951, 85789651, 89521986, 92308880, 93342988, 96025351, 99645193, 103558698, 103854631, 104253666, 104386549, 117886401, 124757847, 125164651, 125433166, 126680944, 129223014, 131856665, 134337710, 134358350, 135067955, 135610269, 135692501, 136352775, 136946635, 137002811, 137053214, 142001694, 152134184, 160650107, 160849672, 160964203, 162037977
|
||||
SuperDrug ATC ID |
G04BE09
|
||||
SuperDrug CAS ID |
cas=224785904
|
||||
Target and Pathway | |||||
Target(s) | CGMP-specific 3',5'-cyclic phosphodiesterase | Target Info | Binder | [535626] | |
KEGG Pathway | Purine metabolism | ||||
cGMP-PKG signaling pathway | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Reactome | cGMP effects | ||||
References | |||||
Ref 536493 | Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007 Sep;12(17-18):757-66. Epub 2007 Aug 27. | ||||
Ref 542344 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7320). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.